These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6140008)

  • 1. Striatal met-enkephalin concentration increases following nigrostriatal denervation.
    Thal LJ; Sharpless NS; Hirschhorn ID; Horowitz SG; Makman MH
    Biochem Pharmacol; 1983 Nov; 32(22):3297-301. PubMed ID: 6140008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase of striatal methionin enkephalin content following lesion of the nigrostriatal dopaminergic pathway in adult rats and reversal following the implantation of embryonic dopaminergic neurons: a quantitative immunohistochemical analysis.
    Manier M; Abrous DN; Feuerstein C; Le Moal M; Herman JP
    Neuroscience; 1991; 42(2):427-39. PubMed ID: 1896133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrastriatal transplants of embryonic dopaminergic neurons counteract the increase of striatal enkephalin immunostaining but not serotoninergic sprouting elicited by a neonatal lesion of the nigrostriatal dopaminergic pathway.
    Abrous DN; Manier M; Mennicken F; Feuerstein C; Le Moal M; Herman JP
    Eur J Neurosci; 1993 Feb; 5(2):128-36. PubMed ID: 7903185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of dopamine D-1 and D-2 receptor subtype agonists on nigrostriatal opioid dynorphin and enkephalin immunostaining in 6-hydroxydopamine lesioned rats.
    Jiang HK; Wang JY
    Chin J Physiol; 1991; 34(4):413-25. PubMed ID: 1687937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin.
    Engber TM; Boldry RC; Kuo S; Chase TN
    Brain Res; 1992 May; 581(2):261-8. PubMed ID: 1356580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nigrostriatal dopamine mediates the stimulatory effects of corticotropin releasing factor on methionine-enkephalin and dynorphin release from the rat neostriatum.
    Sirinathsinghji DJ; Nikolarakis KE; Reimer S; Herz A
    Brain Res; 1990 Aug; 526(1):173-6. PubMed ID: 1981853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of methionine-enkephalin release in the rat striatum by in vivo dialysis: effects of gamma-hydroxybutyrate on cellular and extracellular methionine-enkephalin levels.
    Gobaille S; Schmidt C; Cupo A; Herbrecht F; Maitre M
    Neuroscience; 1994 Jun; 60(3):637-48. PubMed ID: 7936191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical ablation fails to influence striatal dopamine target cell supersensitivity induced by nigrostriatal denervation in the rat.
    Paturle L; Fage D; Fourrier O; Vernier P; Feuerstein C; Demenge P; Scatton B
    Brain Res; 1987 Feb; 402(2):383-6. PubMed ID: 3828803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin-immunoreactive neurons in the rat striatum: effects of corticostriatal and nigrostriatal dopaminergic lesions.
    Salin P; Kerkerian-Le Goff L; Heidet V; Epelbaum J; Nieoullon A
    Brain Res; 1990 Jun; 521(1-2):23-32. PubMed ID: 1976412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D1 dopamine receptor-mediated substance P depletion in the striatonigral neurons of rats subjected to neonatal dopaminergic denervation: implications for self-injurious behavior.
    Sivam SP
    Brain Res; 1989 Oct; 500(1-2):119-30. PubMed ID: 2481560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK; Manzino L; Heikkila RE
    J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supersensitivity time course of dopamine antagonist binding after nigrostriatal denervation: evidence for early and drastic changes in the rat corpus striatum.
    Feuerstein C; Demenge P; Caron P; Barrette G; Guerin B; Mouchet P
    Brain Res; 1981 Dec; 226(1-2):221-34. PubMed ID: 7296288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine receptor sensitivity following nigrostriatal lesion in the aged rat.
    Hirschhorn ID; Makman MH; Sharpless NS
    Brain Res; 1982 Feb; 234(2):357-68. PubMed ID: 7199364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA; Altar CA; Wong CA; Marshall JF
    Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a unilateral 6-hydroxydopamine lesion and prolonged L-3,4-dihydroxyphenylalanine treatment on peptidergic systems in rat basal ganglia.
    Taylor MD; De Ceballos ML; Rose S; Jenner P; Marsden CD
    Eur J Pharmacol; 1992 Aug; 219(2):183-92. PubMed ID: 1385171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage.
    Zhang WQ; Tilson HA; Nanry KP; Hudson PM; Hong JS; Stachowiak MK
    Brain Res; 1988 Oct; 461(2):335-42. PubMed ID: 3141002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D-1 and D-2 dopamine agonists in rat globus pallidus.
    Carlson JH; Bergstrom DA; Demo SD; Walters JR
    Synapse; 1990; 5(2):83-93. PubMed ID: 2309160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible interactions between dynorphin and dopaminergic systems in rat basal ganglia and substantia nigra.
    Quirion R; Gaudreau P; Martel JC; St-Pierre S; Zamir N
    Brain Res; 1985 Apr; 331(2):358-62. PubMed ID: 2859094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal D1 dopamine receptor distribution following chemical lesion of the nigrostriatal pathway.
    Ariano MA
    Brain Res; 1988 Mar; 443(1-2):204-14. PubMed ID: 2965958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.